Literature DB >> 25300549

Algal and microbial exopolysaccharides: new insights as biosurfactants and bioemulsifiers.

José de Jesús Paniagua-Michel1, Jorge Olmos-Soto2, Eduardo Roberto Morales-Guerrero3.   

Abstract

Currently, efforts are being made to utilize more natural biological systems as alternatives as a way to replace fossil forms of carbon. There is a growing concern at global level to have nontoxic, nonhazardous surface-active agents; contrary to synthetic surfactants, their biological counterparts or biosurfactants play a primary function, facilitating microbial presence in environments dominated by hydrophilic-hydrophobic interfaces. Algal and microbial biosurfactants/bioemulsifiers from marine and deep-sea environments are attracting major interest due to their structural and functional diversity as molecules actives of surface and an alternative biomass to replace fossil forms of carbon. Algal and microbial surfactants are lipid in nature and classified as glycolipids, phospholipids, lipopeptides, natural lipids, fatty acids, and lipopolysaccharides. These metabolic bioactive products are applicable in a number of industries and processes, viz., food processing, pharmacology, and bioremediation of oil-polluted environments. This chapter presents an update of the progress and potentialities of the principal producers of exopolysaccharide (EPS)-type biosurfactants and bioemulsifiers, viz., macro- and microalgae (cyanobacteria and diatoms) and bacteria from marine and extreme environments. Particular interest is centered into new sources and applications, viz., marine and deep-sea environments and promissory uses of these EPSs as biosurfactants/emulsifiers and other polymeric roles. The enormous benefits of these molecules encourage their discovery, exploitation, and development of new microbial EPSs that could possess novel industrial importance and corresponding innovations.
© 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Algae; Bacteria; Bioemulsifiers; Bioremediation; Biosurfactants; Exopolysaccharides; Marine

Mesh:

Substances:

Year:  2014        PMID: 25300549     DOI: 10.1016/B978-0-12-800268-1.00011-1

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  7 in total

Review 1.  Biological Functions of Exopolysaccharides from Lactic Acid Bacteria and Their Potential Benefits for Humans and Farmed Animals.

Authors:  María Laura Werning; Annel M Hernández-Alcántara; María Julia Ruiz; Lorena Paola Soto; María Teresa Dueñas; Paloma López; Laureano Sebastián Frizzo
Journal:  Foods       Date:  2022-04-28

Review 2.  Exopolysaccharides from Microalgae and Cyanobacteria: Diversity of Strains, Production Strategies, and Applications.

Authors:  Céline Laroche
Journal:  Mar Drugs       Date:  2022-05-21       Impact factor: 6.085

Review 3.  What Is in Store for EPS Microalgae in the Next Decade?

Authors:  Guillaume Pierre; Cédric Delattre; Pascal Dubessay; Sébastien Jubeau; Carole Vialleix; Jean-Paul Cadoret; Ian Probert; Philippe Michaud
Journal:  Molecules       Date:  2019-11-25       Impact factor: 4.411

Review 4.  Strategies to Obtain Designer Polymers Based on Cyanobacterial Extracellular Polymeric Substances (EPS).

Authors:  Sara B Pereira; Aureliana Sousa; Marina Santos; Marco Araújo; Filipa Serôdio; Pedro Granja; Paula Tamagnini
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

5.  Can Algal Derived Bioactive Metabolites Serve as Potential Therapeutics for the Treatment of SARS-CoV-2 Like Viral Infection?

Authors:  Ankita Bhatt; Pratham Arora; Sanjeev Kumar Prajapati
Journal:  Front Microbiol       Date:  2020-11-11       Impact factor: 5.640

Review 6.  Challenges and perspectives in combinatorial assembly of novel exopolysaccharide biosynthesis pathways.

Authors:  Anke Becker
Journal:  Front Microbiol       Date:  2015-07-09       Impact factor: 5.640

Review 7.  Tiny Microbes with a Big Impact: The Role of Cyanobacteria and Their Metabolites in Shaping Our Future.

Authors:  Sophie Mazard; Anahit Penesyan; Martin Ostrowski; Ian T Paulsen; Suhelen Egan
Journal:  Mar Drugs       Date:  2016-05-17       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.